The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
NCT ID: NCT00063609
Last Updated: 2017-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
200 participants
INTERVENTIONAL
2003-04-30
2005-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients who received any prior bisphosphonate therapy or prior treatment with systemic corticosteroids within in the past 12 months are not eligible to participate. Also patients who are receiving treatment for osteoporosis are not eligible to participate.
Inclusion into this clinical trial with this investigational drug is based on the protocol entry criteria and evaluation from a participating trial investigator.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis
NCT00171639
A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy
NCT00087659
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
NCT00079001
Maintaining Bone Strength in Men With Prostate Cancer
NCT00391950
Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate Cancer
NCT00520052
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
zoledronic acid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Patients who have received prior treatment with systemic corticosteroids within the past 12 months will be excluded (short term corticosteroid therapy, e.g. to prevent/treat chemotherapy-induced nausea/vomiting or for acute illness like asthma exacerbation, is acceptable)
* Other eligibility criteria may apply
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Millennium Therapeutics & Research
Birmingham, Alabama, United States
Medical Affiliated Research Center
Huntsville, Alabama, United States
Alaska Clinical Research Center
Anchorage, Alaska, United States
Advanced Clinical Therapeutics
Tucson, Arizona, United States
Donald Gleason, MD
Tucson, Arizona, United States
Arkansas Urology
Little Rock, Arkansas, United States
Advanced Urology Med. Center
Anaheim, California, United States
Atlantic Urological Medical Group
Long Beach, California, United States
San Diego Uro. Research
San Diego, California, United States
Western Clinical Research
Torrance, California, United States
Connecticut Surgical Group
Hartford, Connecticut, United States
Grove Hill Urology
New Britain, Connecticut, United States
Atlantic Urological Associates
Daytona Beach, Florida, United States
University of Miami School of Medicine, Dept. of Urology
Miami, Florida, United States
Advanced Research Institute, Inc.
New Port Richey, Florida, United States
Urosearch
Ocala, Florida, United States
Southeastern Urological Center, PA
Tallahassee, Florida, United States
Medisphere Medical Research Center, LLC
Evansville, Indiana, United States
The Iowa Clinic, PC, Iowa Urology Research
Des Moines, Iowa, United States
Summitt Clinical Research
Owings Mills, Maryland, United States
Millennium Medical Center
Southfield, Michigan, United States
Quality Clinical Research LLC
Springfield, Nebraska, United States
Associated Urologic Specialist, PA
Marlton, New Jersey, United States
Morristown Memorial Hospital
Morristown, New Jersey, United States
Associates In Urology, LLC
West Orange, New Jersey, United States
AccuMed Research Associates
Garden City, New York, United States
Urological Surgeons of L.I.
Garden City, New York, United States
Staten Island Urological Research, PC
Staten Island, New York, United States
The Urology Group
Cincinnati, Ohio, United States
Urological Associates, Inc.
Columbus, Ohio, United States
Mount Vernon Urological Associates
Mount Vernon, Ohio, United States
Oregon Urology Specialists
Eugene, Oregon, United States
The Urology Clinic
Portland, Oregon, United States
Urologic Associates of Allentown
Allentown, Pennsylvania, United States
Albert Einstein Medical Center
Philadelphia, Pennsylvania, United States
Triangle Urological Group
Pittsburgh, Pennsylvania, United States
Urologic Surgeons of New England, P.C.
Providence, Rhode Island, United States
University Urological Research Institute
Providence, Rhode Island, United States
Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
Integrity Clinical Research, LLC
Germantown, Tennessee, United States
Urology San Antonio Research
San Antonio, Texas, United States
Salt Lake Research
Salt Lake City, Utah, United States
Seattle Urological Associates
Seattle, Washington, United States
Rockwood Clinic
Spokane, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZENITH
Identifier Type: -
Identifier Source: secondary_id
CZOL446GUS45
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.